Detailed information for compound 1602319

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 332.48 | Formula: C20H32N2O2
  • H donors: 2 H acceptors: 2 LogP: 2.8 Rotable bonds: 2
    Rule of 5 violations (Lipinski): 1
  • SMILES: [O]N1C(C)(C)CC(=CC1(C)C)/C=C/C1=CC(N(C(C1)(C)C)[O])(C)C
  • InChi: 1S/C20H32N2O2/c1-17(2)11-15(12-18(3,4)21(17)23)9-10-16-13-19(5,6)22(24)20(7,8)14-16/h9-11,13H,12,14H2,1-8H3/b10-9+
  • InChiKey: JYNYPLGGXKBOQL-MDZDMXLPSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Onchocerca volvulus Steroid hormone receptor family member cnr14 homolog 0.0011 0 0.5
Echinococcus multilocularis NADP dependent isocitrate dehydrogenase 0.2524 1 1
Echinococcus multilocularis isocitrate dehydrogenase 0.2524 1 1
Plasmodium vivax isocitrate dehydrogenase [NADP], mitochondrial, putative 0.2524 1 0.5
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0052 0.016 0.016
Onchocerca volvulus Bile acid receptor homolog 0.0011 0 0.5
Brugia malayi isocitrate dehydrogenase [NAD] subunit beta, mitochondrial 0.0307 0.1175 0.1175
Trypanosoma brucei isocitrate dehydrogenase, putative 0.2524 1 0.5
Toxoplasma gondii isocitrate dehydrogenase 0.2524 1 0.5
Entamoeba histolytica tartrate dehydrogenase, putative 0.0307 0.1175 0.5
Echinococcus granulosus NADP dependent isocitrate dehydrogenase 0.2524 1 1
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0052 0.016 0.016
Wolbachia endosymbiont of Brugia malayi isocitrate dehydrogenase 0.0307 0.1175 0.5
Echinococcus multilocularis NADP dependent isocitrate dehydrogenase 0.2524 1 1
Echinococcus granulosus isocitrate dehydrogenase NAD 0.0307 0.1175 0.1175
Loa Loa (eye worm) isocitrate dehydrogenase gamma subunit 0.0307 0.1175 0.1175
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0052 0.016 0.016
Mycobacterium ulcerans 3-isopropylmalate dehydrogenase 0.0307 0.1175 0.5
Brugia malayi Isocitrate dehydrogenase subunit gamma, mitochondrial precursor 0.0307 0.1175 0.1175
Plasmodium falciparum isocitrate dehydrogenase [NADP], mitochondrial 0.2524 1 0.5
Trypanosoma brucei isocitrate dehydrogenase [NADP], mitochondrial precursor, putative 0.2524 1 0.5
Onchocerca volvulus Protein ultraspiracle homolog 0.0011 0 0.5
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0052 0.016 0.016
Loa Loa (eye worm) isocitrate dehydrogenase 0.2524 1 1
Brugia malayi isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial 0.0307 0.1175 0.1175
Brugia malayi Probable isocitrate dehydrogenase 0.0307 0.1175 0.1175
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0052 0.016 0.016
Echinococcus multilocularis isocitrate dehydrogenase (NAD+) 0.0307 0.1175 0.1175
Loa Loa (eye worm) hypothetical protein 0.0307 0.1175 0.1175
Echinococcus granulosus isocitrate dehydrogenase NAD subunit 0.0307 0.1175 0.1175
Schistosoma mansoni NADP-specific isocitrate dehydrogenase 0.2524 1 1
Schistosoma mansoni unc-13 (munc13) 0.0307 0.1175 0.1175
Mycobacterium tuberculosis Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) 0.2524 1 1
Brugia malayi Probable isocitrate dehydrogenase 0.0307 0.1175 0.1175
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain 0.0052 0.016 0.016
Brugia malayi Isocitrate dehydrogenase 0.2524 1 1
Mycobacterium leprae PROBABLE 3-ISOPROPYLMALATE DEHYDROGENASE LEUB (BETA-IPM DEHYDROGENASE) (IMDH) (3-IPM-DH) 0.0307 0.1175 0.5
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0052 0.016 0.016
Trypanosoma cruzi isocitrate dehydrogenase, putative 0.2524 1 0.5
Schistosoma mansoni Isocitrate dehydrogenase [NAD] subunit gamma mitochondrial 0.0307 0.1175 0.1175
Echinococcus multilocularis NADP dependent isocitrate dehydrogenase 0.2524 1 1
Toxoplasma gondii isocitrate dehydrogenase 0.2524 1 0.5
Echinococcus multilocularis isocitrate dehydrogenase (NAD) subunit 0.0307 0.1175 0.1175
Echinococcus multilocularis isocitrate dehydrogenase 2 (NADP+) 0.2524 1 1
Trypanosoma cruzi isocitrate dehydrogenase [NADP], mitochondrial precursor, putative 0.2524 1 0.5
Leishmania major isocitrate dehydrogenase [NADP], mitochondrial precursor, putative 0.2524 1 1
Schistosoma mansoni isocitrate dehydrogenase 0.0307 0.1175 0.1175
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0052 0.016 0.016
Onchocerca volvulus 0.0011 0 0.5
Trichomonas vaginalis isocitrate dehydrogenase, putative 0.0307 0.1175 0.5
Brugia malayi GTP-binding regulatory protein Gs alpha-S chain, putative 0.0052 0.016 0.016

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.